Nationality Swiss Fields Chemistry | Alma mater ETH Zurich Name Andreas Pfaltz Thesis 1978 | |
 | ||
Born 10 May 1948 (age 75)
Basel, Switzerland ( 1948-05-10 ) Institutions University of Basel
Max Planck Institute for Coal Research
ETH Zurich Known for chiral ligands, coordination chemistry and catalysis Notable awards Pracejus Prize (2003)
Prelog Medal (2003)
Ryoji Noyori Prize (2008) Institution University of Basel, Max Planck Institute for Coal Research, ETH Zurich | ||
Doctoral advisor Albert Eschenmoser | ||
Andreas Pfaltz (born 10 May 1948) is a Swiss chemist known for his work in the area of coordination chemistry and catalysis.
Contents
Education and professional life
Andreas Pfaltz studied at ETH Zurich, completing his undergraduate diploma in natural sciences in 1972 and his PhD in organic chemistry in 1978. His doctoral supervisor was Albert Eschenmoser, whose research into vitamin B12 and other corrin rings would influence Pfaltz's early research. Following a two-year postdoctoral position at Columbia University (early 1978 – late 1979), working for Gilbert Stork on the synthesis of Rifamycin, he returned to ETH Zurich as a lecturer and began his own research. In 1990 he was appointed as an associate professor at the University of Basel, becoming a full professor in 1993. Between 1995 and 1998 he was a director of the prestigious Max Planck Institute for Coal Research, afterwards returning to the University of Basel, where he has remained till the present day.
Research
Pfaltz's early research was influenced by his PhD supervisor Albert Eschenmoser and was largely based around the synthesis of corrins, porphyrins and other macrocycles. During the second half of the 1980s he began to use fragments of these macrocycles as novel ligands for asymmetric catalysis, with chiral C2-symmetric semicorrins being the most successful example. Following the development of structurally related bis(oxazoline)s Pfaltz began using and developing various oxazoline based ligands, making significant contributions to the known chemistry of phosphinooxazolines. His current research activities remain focused on ligand development, asymmetric catalysis and catalyst screening.